ArticleCellular oncology (Dordrecht, Netherlands)2024

Targeting ONECUT3 blocks glycolytic metabolism and potentiates anti-PD-1 therapy in pancreatic cancer.

Peng-Cheng Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.